{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:41:02Z","timestamp":1790311262005,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-023-03052-7","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T06:01:36Z","timestamp":1695448896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Liver resection for metastatic GIST tumor improves survival in the era of tyrosine kinase inhibitors: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"408","author":[{"given":"Arash","family":"Rahimi-Ardabily","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Murdande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie W.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krist","family":"Aploks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9324-1281","authenticated-orcid":false,"given":"Xiang","family":"Da Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,23]]},"reference":[{"issue":"6","key":"3052_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000478-198309000-00001","volume":"7","author":"MT Mazur","year":"1983","unstructured":"Mazur MT, Clark HB (1983) Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 7(6):507\u2013519","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3052_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00000478-199502000-00009","volume":"19","author":"M Miettinen","year":"1995","unstructured":"Miettinen M, Virolainen M, Maarit SR (1995) Gastrointestinal stromal tumors\u2014value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol 19(2):207\u2013216","journal-title":"Am J Surg Pathol"},{"issue":"5350","key":"3052_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Sci 279(5350):577\u2013580","journal-title":"Sci"},{"issue":"5","key":"3052_CR4","first-page":"1259","volume":"152","author":"LG Kindblom","year":"1998","unstructured":"Kindblom LG, Remotti HE, Aldenborg F et al (1998) Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152(5):1259\u20131269","journal-title":"Am J Pathol"},{"issue":"12","key":"3052_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nrc3143","volume":"11","author":"CL Corless","year":"2011","unstructured":"Corless CL, Barnett CM, Heinrich MC (2011) Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer 11(12):865\u2013878","journal-title":"Nat Rev Cancer"},{"key":"3052_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/1209","volume":"19","author":"T Nishida","year":"1998","unstructured":"Nishida T, Hirota S, Taniguchi M et al (1998) Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet 19:323\u2013324","journal-title":"Nat Genet"},{"issue":"5","key":"3052_CR7","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0016-5085(98)70079-4","volume":"115","author":"M Nakahara","year":"1998","unstructured":"Nakahara M, Isozaki K, Hirota S et al (1998) A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterol 115(5):1090\u20131095","journal-title":"Gastroenterol"},{"issue":"22","key":"3052_CR8","first-page":"8118","volume":"61","author":"BP Rubin","year":"2001","unstructured":"Rubin BP, Singer S, Tsao C et al (2001) KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 61(22):8118\u20138121","journal-title":"Cancer Res"},{"issue":"5607","key":"3052_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1126\/science.1079666","volume":"299","author":"MC Heinrich","year":"2003","unstructured":"Heinrich MC, Corless CL, Duensing A et al (2003) PDGFRA activating mutations in gastrointestinal stromal tumors. Sci 299(5607):708\u2013710","journal-title":"Sci"},{"key":"3052_CR10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/modpathol.2013.173","volume":"27","author":"CL Corless","year":"2014","unstructured":"Corless CL (2014) Gastrintestinal stromal tumors: what do we know now? Mod Pathol 27:S1\u2013S16. https:\/\/doi.org\/10.1038\/modpathol.2013.173","journal-title":"Mod Pathol"},{"issue":"1","key":"3052_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00000478-199901000-00009","volume":"23","author":"TS Emory","year":"1999","unstructured":"Emory TS, Sobin LH, Lukes L et al (1999) Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 23(1):82\u201387","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3052_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00000658-200001000-00008","volume":"231","author":"RP DeMatteo","year":"2000","unstructured":"DeMatteo RP, Lewis JJ, Leung D et al (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231(1):51\u201358","journal-title":"Ann Surg"},{"issue":"14","key":"3052_CR13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1056\/NEJM200104053441404","volume":"344","author":"H Joensuu","year":"2001","unstructured":"Joensuu H, Roberts PJ, Sarlomo-Rikala M et al (2001) Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344(14):1052\u20131056","journal-title":"N Engl J Med"},{"issue":"4","key":"3052_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.soc.2013.06.001","volume":"22","author":"VP Balachandran","year":"2013","unstructured":"Balachandran VP, Dematteo RP (2013) Targeted therapy for cancer: the gastrointestinal stromal tumor model. Surg Oncol Clin N Am 22(4):805\u2013821","journal-title":"Surg Oncol Clin N Am"},{"issue":"9","key":"3052_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1200\/JCO.2006.09.0183","volume":"25","author":"JY Blay","year":"2007","unstructured":"Blay JY, Le Cesne A, Ray-Coquard I et al (2007) Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group. J Clin Oncol 25(9):1107\u20131113","journal-title":"J Clin Oncol"},{"issue":"7","key":"3052_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1056\/NEJMoa020461","volume":"347","author":"GD Demetri","year":"2002","unstructured":"Demetri GD, von Mehren M, Blanke CD et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347(7):472\u2013480","journal-title":"N Engl J Med"},{"issue":"10","key":"3052_CR17","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1470-2045(10)70222-9","volume":"11","author":"A Le Cesne","year":"2010","unstructured":"Le Cesne A, Ray-Coquard I, Bui BN et al (2010) Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial. Lancet Oncol 11(10):942\u2013949","journal-title":"Lancet Oncol"},{"issue":"9544","key":"3052_CR18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(06)69446-4","volume":"368","author":"GD Demetri","year":"2006","unstructured":"Demetri GD, van Oosterom AT, Garrett CR et al (2006) Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 368(9544):1329\u20131338","journal-title":"Lancet"},{"issue":"3","key":"3052_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/01.sla.0000242710.36384.1b","volume":"245","author":"A Gronchi","year":"2007","unstructured":"Gronchi A, Fiore M, Miselli F et al (2007) Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced\/metastatic GIST. Ann Surg 245(3):341\u2013346","journal-title":"Ann Surg"},{"issue":"3","key":"3052_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/01.sla.0000236630.93587.59","volume":"245","author":"RP DeMatteo","year":"2007","unstructured":"DeMatteo RP, Maki RG, Singer S et al (2007) Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Ann Surg 245(3):347\u2013352","journal-title":"Ann Surg"},{"key":"3052_CR21","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Green S (2011) Cochrane handbook for systematic reviews of interventions, vol 4. John Wiley & Sons, England"},{"key":"3052_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336\u2013341","journal-title":"Int J Surg"},{"key":"3052_CR23","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008\u20132012","journal-title":"JAMA"},{"issue":"8","key":"3052_CR24","doi-asserted-by":"publisher","first-page":"e20294","DOI":"10.1371\/journal.pone.0020294","volume":"6","author":"F Ducimetiere","year":"2011","unstructured":"Ducimetiere F, Lurkin A, Ranchere-Vince D et al (2011) Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One 6(8):e20294","journal-title":"PLoS One"},{"issue":"10","key":"3052_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s00595-009-4171-x","volume":"40","author":"L Xia","year":"2010","unstructured":"Xia L, Zhang MM, Ji L et al (2010) Resection combined with imatinib therapy for liver metastases of gastrointestinal stromal tumors. Surg Today 40(10):936\u2013942","journal-title":"Surg Today"},{"issue":"10","key":"3052_CR26","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.ejca.2014.03.280","volume":"50","author":"CY Du","year":"2014","unstructured":"Du CY, Zhou Y, Song C et al (2014) Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China. Eur J Cancer 50(10):1772\u20131778","journal-title":"Eur J Cancer"},{"key":"3052_CR27","first-page":"369","volume":"47","author":"T Kanda","year":"2017","unstructured":"Kanda T, Masuzawa T, Hirai T, Ikawa O, Takagane A, Hata Y, Ojima H, Sodeyama H, Mochizuki I, Ishikawa T, Kagimura T, Nishida T (2017) Surgery and imatinib therapy for liver oligometastasis of GIST: a study of Japanese study group on GIST. Jpn J Clin Oncol 47:369\u2013372","journal-title":"Jpn J Clin Oncol"},{"issue":"46","key":"3052_CR28","doi-asserted-by":"publisher","first-page":"e8240","DOI":"10.1097\/MD.0000000000008240","volume":"96","author":"YN Shi","year":"2017","unstructured":"Shi YN, Li Y, Wang LP et al (2017) Gastrointestinal stromal tumor (GIST) with liver metastases: an 18-year experience from the GIST cooperation group in North China. Med 96(46):e8240","journal-title":"Med"},{"issue":"1","key":"3052_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00595-016-1351-3","volume":"47","author":"S Sato","year":"2016","unstructured":"Sato S, Tsujinaka T, Masuzawa T et al (2016) Role of metastasectomy for recurrent\/metastatic gastrointestinal stromal tumors based on an analysis of the Kinki Gist Registry. Surg Today 47(1):58\u201364","journal-title":"Surg Today"},{"issue":"2","key":"3052_CR30","doi-asserted-by":"publisher","first-page":"e9097","DOI":"10.1097\/MD.0000000000009097","volume":"97","author":"HB Qiu","year":"2018","unstructured":"Qiu HB, Zhou ZG, Feng XY, Liu XC, Guo J, Ma MZ, Chen YB, Sun XW, Zhou ZW (2018) Advanced gastrointestinal stromal tumor patients benefit from palliative surgery after tyrosine kinase inhibitors therapy. Med 97(2):e9097","journal-title":"Med"},{"key":"3052_CR31","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.2147\/CMAR.S187061","volume":"10","author":"B Xiao","year":"2018","unstructured":"Xiao B, Peng J, Tang J et al (2018) Liver surgery prolongs the survival of patients with gastrointestinal stromal tumor liver metastasis: a retrospective study from a single center. Cancer Manag Res 10:6121\u20136127","journal-title":"Cancer Manag Res"},{"issue":"24","key":"3052_CR32","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1097\/MD.0000000000001014","volume":"94","author":"SC Chang","year":"2015","unstructured":"Chang SC, Liao CH, Wang SY et al (2015) Feasibility and timing of cytoreduction surgery in advanced (metastatic or recurrent) gastrointestinal stromal tumors during the era of Imatinib. Med 94(24):e1014","journal-title":"Med"},{"issue":"2","key":"3052_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jss.2012.07.005","volume":"177","author":"V Zaydfudim","year":"2012","unstructured":"Zaydfudim V, Okuno SH, Que FG et al (2012) Role of operative therapy in treatment of metastatic gastrointestinal stromal tumors. J Surg Res 177(2):248\u2013254","journal-title":"J Surg Res"},{"key":"3052_CR34","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.hpb.2021.11.011","volume":"24","author":"TL Sutton","year":"2022","unstructured":"Sutton TL, Walker BS, Billingsley KG et al (2022) Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy alone. HPB 24:986\u2013993","journal-title":"HPB"},{"key":"3052_CR35","doi-asserted-by":"publisher","first-page":"903487","DOI":"10.3389\/fonc.2022.903487","volume":"12","author":"A Xue","year":"2022","unstructured":"Xue A, Gao X, He Y et al (2022) Role of surgery in the management of liver metastases from gastrointestinal stromal tumors. Front Oncol 12:903487","journal-title":"Front Oncol"},{"issue":"5","key":"3052_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1053\/hupa.2002.123545","volume":"33","author":"CD Fletcher","year":"2002","unstructured":"Fletcher CD, Berman JJ, Corless C et al (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33(5):459\u2013465","journal-title":"Hum Pathol"},{"issue":"9","key":"3052_CR37","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1007\/s11605-008-0501-3","volume":"12","author":"CP Raut","year":"2008","unstructured":"Raut CP, Ashley SW (2008) How I do it: surgical management of gastrointestinal stromal tumors. J Gastrointest Surg 12(9):1592\u20131599","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"3052_CR38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11864-001-0070-0","volume":"2","author":"CD Blanke","year":"2001","unstructured":"Blanke CD, Eisenberg BL, Heinrich MC (2001) Gastrointestinal stromal tumors. Curr Treat Options in Oncol 2(6):485\u2013491","journal-title":"Curr Treat Options in Oncol"},{"issue":"24","key":"3052_CR39","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1200\/JCO.2005.11.601","volume":"23","author":"M Van Glabbeke","year":"2005","unstructured":"Van Glabbeke M, Verweij J, Casali PG, Le Cesne A, Hohenberger P, Ray-Coquard I, Schlemmer M, van Oosterom AT, Goldstein D, Sciot R, Hogendoorn PC, Brown M, Bertulli R, Judson IR (2005) Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study. J Clin Oncol 23(24):5795\u20135804","journal-title":"J Clin Oncol"},{"issue":"12","key":"3052_CR40","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1245\/s10434-006-9047-3","volume":"13","author":"S Bonvalot","year":"2006","unstructured":"Bonvalot S, Eldweny H, Pechoux CL et al (2006) Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era. Ann Surg Oncol 13(12):1596\u20131603","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"3052_CR41","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1200\/JCO.2005.05.3439","volume":"24","author":"CP Raut","year":"2006","unstructured":"Raut CP, Posner M, Desai J et al (2006) Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol 24(15):2325\u20132331","journal-title":"J Clin Oncol"},{"issue":"4","key":"3052_CR42","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/jso.20466","volume":"93","author":"P Rutkowski","year":"2006","unstructured":"Rutkowski P, Nowecki Z, Nyckowski P et al (2006) Surgical treatment of patients with initially inoperable and\/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate. J Surg Oncol 93(4):304\u2013311","journal-title":"J Surg Oncol"},{"issue":"1","key":"3052_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1245\/s10434-006-9034-8","volume":"14","author":"RH Andtbacka","year":"2007","unstructured":"Andtbacka RH, Ng CS, Scaife CL et al (2007) Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 14(1):14\u201324","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3052_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1200\/JCO.2017.74.9705","volume":"36","author":"M Von Mehren","year":"2018","unstructured":"Von Mehren M, Joensuu H (2018) Gastrointestinal stromal tumors. J Clin Oncol 36(2):136\u2013143","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"3052_CR45","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1038\/modpathol.2008.9","volume":"21","author":"CR Antonescu","year":"2008","unstructured":"Antonescu CR (2008) Targeted therapy of cancer: new roles for pathologists in identifying GISTs and other sarcomas. Mod Pathol 21(Suppl 2):S31\u2013S36","journal-title":"Mod Pathol"},{"issue":"2","key":"3052_CR46","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/01.sla.0000218080.94145.cf","volume":"244","author":"JS Gold","year":"2006","unstructured":"Gold JS, Dematteo RP (2006) Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Ann Surg 244(2):176\u2013184","journal-title":"Ann Surg"},{"key":"3052_CR47","doi-asserted-by":"publisher","first-page":"659","DOI":"10.14694\/EdBook_AM.2012.32.209","volume":"32","author":"J Verweij","year":"2012","unstructured":"Verweij J (2012) Adjuvant treatment of gastrointestinal stromal tumor: the proof, the pro, and the practice. Am Soc Clin Oncol Educ Book 32:659\u2013662","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"3","key":"3052_CR48","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/sj.bjc.6600965","volume":"89","author":"P B\u00fcmming","year":"2003","unstructured":"B\u00fcmming P, Andersson J, Meis-Kindblom JM, Klingenstierna H, Engstr\u00f6m K, Stierner U, W\u00e4ngberg B, Jansson S, Ahlman H, Kindblom LG, Nilsson B (2003) Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients. Br J Cancer 89(3):460\u2013464","journal-title":"Br J Cancer"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03052-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-023-03052-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03052-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T17:08:12Z","timestamp":1705597692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-023-03052-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3052"],"URL":"https:\/\/doi.org\/10.1007\/s00423-023-03052-7","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,23]]},"assertion":[{"value":"6 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Systemic review of published data. N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}